3VA-85670-87001
3 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 630 / MO
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
-
2021-05-27
Survey response — day 35, dose 2MedDRA: Cough, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Fever, sore throat, cough, runny nose, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
-
2021-07-22
Survey response — 3 months, dose 2MedDRA: Cough — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CoughingMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-26
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: I've had Covid since the last time I've checked in but didn't experience any symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Dose 3 — Pfizer-BioNTech
- 2022-04-22
- 2022-05-02
- 2022-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-11-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-22 | Unsuccessful |
Free text
Release 8 — day 35, dose 2
Symptoms: Fever, sore throat, cough, runny nose, congestion
Release 9 — 3 months, dose 2
Symptoms: Coughing
Release 10 — 6 months, dose 2
Symptoms: I've had Covid since the last time I've checked in but didn't experience any symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release